PD1+ Tumor Associated Macrophages Predict Poor Prognosis of Locally Advanced Esophageal Squamous Cell Carcinoma

Oct 16, 2019Future oncology (London, England)

Immune cells with PD1 in esophageal cancer linked to worse outcomes

AI simplified

Abstract

CD68PD1 macrophages increased approximately 4.2 times in cancer tissues compared to para-cancer tissues.

  • CD68PD1 macrophages express higher levels of M2 markers in esophageal squamous cell carcinoma (ESCC).
  • These macrophages are significantly associated with more aggressive cancer traits and poorer patient outcomes.
  • Treatment with PD1 can enhance the ability of macrophages to engulf cancer cells and promote a shift towards a more aggressive M1-like phenotype.
  • Overall, CD68PD1 macrophages may serve as a prognostic indicator for ESCC.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free